NVLS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, Nivalis Therapeutics Inc's share price is $2.74. Nivalis Therapeutics Inc's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was $-1.70. Hence, Nivalis Therapeutics Inc's Price-to-Free-Cash-Flow Ratio for today is .
Nivalis Therapeutics Inc's Free Cash Flow per Share for the three months ended in Dec. 2016 was $-0.34. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was $-1.70.
Nivalis Therapeutics Inc's Price-to-Free-Cash-Flow ratio for today is calculated as
|Price-to-Free-Cash-Flow Ratio||=||Share Price||/||Free Cash Flow per Share (TTM)|
Nivalis Therapeutics Inc's Share Price of today is $2.74.
Nivalis Therapeutics Inc's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was -0.455 (Mar. 2016 ) + -0.426 (Jun. 2016 ) + -0.486 (Sep. 2016 ) + -0.335 (Dec. 2016 ) = $-1.70.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, managements decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Nivalis Therapeutics Inc Annual Data
Nivalis Therapeutics Inc Quarterly Data